tREACH trial of 120 early arthritis pts shows risk factors for persistence are predictive: Serpositivity, polyarthritis (>4), erosive Dz, high ESR/CRP. Those w/ 0, 1 and ≥2 risk factors had a 61%, 32% and 30% (respective) chance of drug free remission. https://t.co/AsCLGu4Vye